CRISPR Therapeutics AG 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Samarth Kulkarni | 16 | -375,337 |
James R. Kasinger | 2 | -5,860 |
Raju Prasad | 1 | -3,524 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 19,582 | -19,582 |
最近3个月 | 0 | 139,721 | -139,721 |
最近6个月 | 0 | 159,721 | -159,721 |
最近12个月 | 0 | 184,721 | -184,721 |
最近18个月 | 0 | 334,721 | -334,721 |
最近36个月 | 0 | 409,721 | -409,721 |
CRISPR Therapeutics AG 内部交易
CRISPR Therapeutics AG 最新内部交易
Samarth Kulkarni | CEO | 2024-04-15 | 卖出 | 19,582 | 408,122 |
$59.91
|
-10.02%
|
Samarth Kulkarni | CEO | 2024-03-15 | 卖出 | 20,000 | 408,122 |
$72.48
|
-25.62%
|
Raju Prasad | CFO | 2024-03-15 | 卖出 | 3,524 | 6,476 |
$72.69
|
-25.84%
|
Samarth Kulkarni | CEO | 2024-03-12 | 卖出 | 14,385 | 408,122 |
$77.04
|
-30.02%
|
James R. Kasinger | General Counsel & Secretary | 2024-03-12 | 卖出 | 3,947 | 61,174 |
$77.15
|
-30.12%
|
Samarth Kulkarni | CEO | 2024-02-20 | 卖出 | 6,370 | 394,257 |
$79.67
|
-32.33%
|
James R. Kasinger | General Counsel & Secretary | 2024-02-20 | 卖出 | 1,913 | 57,371 |
$79.67
|
-32.33%
|
Samarth Kulkarni | CEO | 2024-02-15 | 卖出 | 20,000 | 387,377 |
$80.36
|
-32.91%
|
Samarth Kulkarni | CEO | 2024-01-29 | 卖出 | 50,000 | 387,377 |
$60.51
|
-10.91%
|
Samarth Kulkarni | CEO | 2024-01-16 | 卖出 | 20,000 | 387,377 |
$62.5
|
-13.74%
|